Supernus Pharmaceuticals reported $8.52M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
ANI Pharmaceuticals USD 74.41M 585K Sep/2026
Aurora Cannabis CAD 56.83M 47.52M Jun/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Canopy Growth CAD 28.61M 6.21M Jun/2026
Cara Therapeutics USD 2.08M 2.54M Sep/2026
Corcept Therapeutics USD 21.92M 7.01M Sep/2026
Eisai JPY 81.67B 5.86B Sep/2026
Eli Lilly USD 5.79B 319M Sep/2026
Novo Nordisk DKK 14.59B 212M Jun/2026
Perrigo USD 390.5M 9.9M Sep/2026
Pfizer USD 4.07B 511M Sep/2026
Supernus Pharmaceuticals USD 8.52M 2.92M Sep/2026
United Therapeutics USD 520.2M 22.4M Sep/2026
Xeris Pharmaceuticals USD 8.04M 1.3M Sep/2026